10 May 2022
AMTE POWER PLC
("AMTE Power" or the "Company")
Appointment of Joint Broker
AMTE Power Plc ("AMTE Power" or the "Company"), the developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist market, is pleased to announce the appointment, with immediate effect, of Panmure Gordon as the Company's Joint Broker, alongside WH Ireland, who will retain their role as NOMAD and Joint Broker.
Enquiries
| AMTE Power plc | Tel: +44 (0)1847 867 200 |
| Kevin Brundish (Chief Executive Officer) | |
| James Hobson (Chief Financial Officer) | |
| | |
| Panmure Gordon (UK) Limited (Joint Broker) | Tel: +44 (0)207 886 2500 |
| John Prior / Harriette Johnson (Corporate Finance) Hugh Rich (Corporate Broking) | |
| | |
| WH Ireland (NOMAD and Joint Broker) | Tel: +44 (0)207 220 1666 |
| Chris Fielding / Ben Good | |
| | |
| Camarco | Tel: +44 (0)20 3757 4992 |
| Ginny Pulbrook / Tom Huddart / Rosie Driscoll | |
Notes to Editors:
AMTE Power was founded in 2013 and is a leading developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets. In March 2021, the Company listed on the AIM market of the London Stock Exchange. The Company is focused on launching a series of next generation battery cells based on new chemistries and cell structures that are designed to solve key problems in power delivery, energy performance, and safety. These new products are targeted at a range of specialist markets including the electric vehicle industry and energy storage sector. AMTE Power's purpose-built cell manufacturing facility in Thurso, Scotland has the second largest cell manufacturing capacity in the UK and the Company also has a product development team based in Oxford.
For further information visit the Company's website: www.amtepower.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
